Atlas Trials

Saltikva for Metastatic Pancreatic Cancer

Clinical trial NCT04589234 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04589234
Sponsor
Salspera LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Cancer
Start date
2020-10-20
Primary completion
2030-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.